Horizon Financial Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-45
Closed -$2.13K 382
2025
Q4
$2.29K Buy
+45
New +$2.3K ﹤0.01% 306
2025
Q3
Sell
-8
Closed -$468 371
2025
Q2
$552 Hold
8
﹤0.01% 287
2025
Q1
$556 Hold
8
﹤0.01% 261
2024
Q4
$688 Hold
8
﹤0.01% 229
2024
Q3
$953 Hold
8
﹤0.01% 230
2024
Q2
$1.14K Hold
8
﹤0.01% 209
2024
Q1
$1.03K Buy
+8
New +$952 ﹤0.01% 221
2022
Q1
Sell
-170
Closed -$9.52K 93
2021
Q4
$9.52K Hold
170
0.01% 96
2021
Q3
$8K Hold
170
0.01% 111
2021
Q2
$7K Buy
+170
New +$6.59K 0.01% 103

Other funds holding NVO

Horizon Financial Services's NVO Position: Q1 2026 in Review

Horizon Financial Services sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 45 shares — an estimated $2.13K sold.

Horizon Financial Services first reported a position in NVO in Q2 2021 and held it in 10 quarters. The position peaked at $9.52K in Q4 2021. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Horizon Financial Services reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Horizon Financial Services sold 45 Novo Nordisk shares in Q1 2026, an estimated $2.13K.
  • Horizon Financial Services first reported a position in Novo Nordisk in Q2 2021 and held it in 10 quarters.
  • Horizon Financial Services's Novo Nordisk position peaked at $9.52K in Q4 2021.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Horizon Financial Services's 13F filing for Q1 2026, filed 15 Apr 2026.